4/A
Changes in Ownership
HCW Biologics Inc. Filed Acc 0001209191-21-055532
Chief Financial Officer bought 10,000 shares at $4.40 ($43,979)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Byam Rebecca Chief Financial Officer | 2021-08-19 | Purchase | +10,000 | $4.40 | $43,979 | 62,000 | D |
| Open-market purchases · 10,000 sh · avg $4.40 · $43,979 | |||||||
Loading xslF345X03/doc4a.xml…